The capsules are designed to only be used with the HandiHaler breath-activated inhalation device (Boehringer Ingelheim, Ridgefield, CT). Although the manufacturer does not provide dosage ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The heritage of Boehringer Ingelheim in developing medicines for ... Airway wall thickness, emphysema and air trapping are being assessed using CT. By correlating patient characteristics ...

She's currently the Chief Medical Officer and Head of Medicine at Boehringer Ingelheim. Well, Dr. Hinsch Gylvin. Thanks for joining me today. That really has changed. So first and foremost ...

Boehringer Ingelheim has taken an option on a family ... Also in late-stage testing is Click Therapeutics-partnered DTx CT-155, which also has breakthrough status from the FDA for the negative ...

Boehringer Ingelheim, through our ‘Taking Cancer On’ strategy, has a long-term commitment to deliver scientific breakthroughs and develop innovative cancer treatments to positively transform ...

The candidates seek to represent the 111th House District, which covers over 90 percent of Ridgefield and has been represented by Berger-Girvalo for two terms. Before Berger-Girvalo won her ...

Angiotensin-II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Currently, AT-II-receptor antagonists are used either as monotherapy in ...

Management of AF from a rate control or rhythm control perspective has been studied via a meta-analysis of 5 randomized trials. 7 Rate control in combination with anticoagulation as front-line ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.